Home/Pulmotect/Colin Broom

CB

Colin Broom

Chief Executive Officer

Therapeutic Areas

Infectious Disease Pulmonology Oncology Supportive Care

Pulmotect Pipeline

Drug	Indication	Phase
PUL-042	Prevention of respiratory infections (viral, bacterial, fungal) in immunocompromised patients	Phase 2

Leadership Team at Pulmotect

Leo Linbeck III

Chairman of the Board

Co-Founder, Board Director

Atul Varadhachary

View full Pulmotect profile